Other terms
- Posterior Segment
- Postmenopausal Osteoporosis
- Postprandial Distress Syndrome (PDS)
- Pre-treatment Genomic-Based Cancer Screening
- Precision GI Medicine
- Precision Medicine
- Precision Oncology
- Presbyopia
- PDUFA
- Proteomics
- Protocol
- Protocol Amendments
Pompe Disease
What is Pompe Disease? Pompe disease is a glycogen type lysosomal storage disease. It is an autosomal recessive disease caused by the mutation in the gene for acid alfa-glucosidase that leads to unstable mRNA that cannot be translated to form a sufficient quantity of enzyme. As acid alfa-glucosidase is an enzyme used by the lysosome to metabolize glycogen, a deficiency causes the accumulation of glycogen.
Signs and Symptoms of Pompe Disease
Pompe disease is classified based on the onset of disease, infantile-onset and late-onset, which depends on the amount of acid alpha-glycosidase present. In both classes, the accumulated glycogen is implicated in the damage of striated muscle cells, affecting distal voluntary muscles first. Damage to cardiac muscle and the diaphragm is seen at the end of the disease and contributes to mortality.
Infantile-onset Pompe disease is diagnosed at birth and is more severe. Symptoms may include:
- Hypotonia/weakness of muscles
- Motor delay
- Cardiomegaly
- Hepatomegaly
- Macroglossia
- Faltering growth
- Respiratory failure
Late-onset Pompe disease is often recognized in childhood through symptoms such as:
- Proximal muscle weakness
- Lower limb weakness
Source: Unnisa, Z., Yoon, J. K., Schindler, J. W., Mason, C., & van Til, N. P. (2022). Gene Therapy Developments for Pompe Disease. Biomedicines, 10(2), 302. https://doi.org/10.3390/biomedicines10020302
